{"SPADE_UN_11343": {"Clinical Information": [{"Medical use": "Type 1 diabetes mellitus", "Company": "DeveloGen", "Stage of Development": "Phase III", "Comments": "No more comments", "Clinical Trials": ["NCT00058981", "NCT00615264", "NCT00644501", "NCT01103284", "NCT01460251", "NCT01881958", "NCT01898286"]}], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11343", "Peptide Name": "DiaPep277", "Sequence": "VLGGGVALLRVIPALDSLKPANED", "Source": "DiaPep277 is a small, lyophilized powder containing 24 Amino-acids. It has proved in former studies that DiaPep277 can slow down beta cells destruction in the pancreas and therefore decelerate the progress of Diabetes.", "Target Organism": "No MICs found on DRAMP database", "Reference": ["Potential of immunomodulatory host defense peptides as novel anti-infectives.Trends in Biotechnology(2009).(PMID:19683819)"], "Biological Activity": ["Unknown"], "Frequent Amino Acids": "LAG", "Absent Amino Acids": "CFHMOQTUWY", "Basic Residues": 2, "Acidic Residues": 3, "Hydrophobic Residues": 14, "Polar Residues": 10, "Positive Residues": 2, "Negative Residues": 3, "Mass": 2417.8, "PI": 4.78, "Net Charge": -1, "Hydrophobicity": 0.58, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00253", "Similarity": 0.6, "Sequence": "YKRGGGGWGGGGGWKGGGGGGGGWKGGGGGGKGGGG"}, {"SPADE_ID": "SPADE_UN_01559", "Similarity": 0.6, "Sequence": "GGGGGGSMFGGAKKRSGGGGGG"}, {"SPADE_ID": "SPADE_UN_13005", "Similarity": 0.6, "Sequence": "GGGGGGG"}]}}}